This chapter contains sections titled: Introduction Recombinant Therapeutic Proteins Definition of Biosimilars Regulatory Situation Patent Situation First Wave of Biosimilars in the EU Biosimilar Targets: Second Wave of Future Biosimilars Biosimilar Developments and Requirements Conclusions References